Split crRNA-motivated amplification-free RNA testing with CRISPR–Cas12a

被引:0
|
作者
Jiayu Zeng
Pengfei Liu
Jinlian Du
Sheng Li
Erhu Xiong
Ronghua Yang
机构
[1] KeyLaboratoryofChemicalBiology&TraditionalChineseMedicineResearch,MinistryofEducation,CollegeofChemistryandChemicalEngineering,HunanNormalUniversity
关键词
D O I
暂无
中图分类号
Q78 [基因工程(遗传工程)];
学科分类号
071007 ; 0836 ; 090102 ;
摘要
The CRISPR RNA(crRNA) consists of a conserved repeat RNA(rRNA) and an alterable spacer RNA(sRNA), which can guide the Cas12a effector to recognize and target DNA molecules of interest in both full-length and split fashion. We herein demonstrated the split crRNA can be repurposed for RNA detection through serving the sRNA as an RNA target. Inspired by this phenomenon, we developed a Cas12a-based direct RNA detection method, known as split crRNA-motivated amplification-free RNA testing(SMART). We adopted SMART to detect both short-stranded and long-stranded RNA target using two Cas12a orthologs(LbCas12a and FnCas12a), and it showed more prominent ability in detecting short-stranded RNA than long-stranded RNA. The potential mechanism revealed that RNA overhangs impede the RNA strand and dsDNA activator from accessing the catalytic site in the RuvC domain of the Cas12a effector, compromising the stability of the quaternary complex, and thus reducing the efficiency of SMART. Surprisingly, by simply introducing a short DNA activator, SMART could detect attomolar miRNA targets and femtomolar long-stranded RNA target without the need for additional preamplification or reverse transcription procedures. In addition, SMART showed wonderful discrimination ability toward single-nucleotide mutations.Moreover, the collaboration of SMART with the CRISPR–Cas13a system enabled simultaneous detection of multiplex RNAs.Overall, SMART is a simple, yet potent tool that can be flexibly applied to various short-stranded RNA detection, and holds great potential to be extended to other Cas12 orthologs.
引用
收藏
页码:789 / 801
页数:13
相关论文
共 50 条
  • [41] CRISPR-Cas, Argonaute proteins and the emerging landscape of amplification-free diagnostics
    Santiago-Frangos, Andrew
    Nemudryi, Artem
    Nemudraia, Anna
    Wiegand, Tanner
    Nichols, Joseph E.
    Krishna, Pushya
    Scherffius, Andrew M.
    Zahl, Trevor R.
    Wilkinson, Royce A.
    Wiedenheft, Blake
    METHODS, 2022, 205 : 1 - 10
  • [42] A Fully Automated Point-of-Care Device Using Organic Electrochemical Transistor-Enhanced CRISPR/Cas12a for Amplification-Free Nucleic Acid Detection
    Chen, Jing
    Yang, Deqi
    Ji, Daizong
    Guo, Bihan
    Guo, Yuqian
    Lin, Huiping
    Zhang, Ru
    Chang, Zhiqiang
    Lu, Yuhan
    Zhu, Guoqi
    Zhao, Lei
    Rungrotmongkol, Thanyada
    Lu, Xinxin
    Ren, Qinjuan
    Wu, Wenjuan
    Zhang, Ya
    Fang, Yin
    ADVANCED FUNCTIONAL MATERIALS, 2025,
  • [43] A CRISPR/Cas12a-SERS platform for amplification-free detection of African swine fever virus genes
    Wang, Huimin
    Su, Ailing
    Bao, Chengxin
    Liang, Chongyang
    Xu, Weiqing
    Chang, Jingjing
    Xu, Shuping
    TALANTA, 2024, 267
  • [44] Amplification-free detection of plant pathogens by improved CRISPR-Cas12a systems: a case study on phytoplasma
    Lagner, Joseph R.
    Newberry, Eric A.
    Rivera, Yazmin
    Zhang, Liyang
    Vakulskas, Christopher A.
    Qi, Yiping
    FRONTIERS IN PLANT SCIENCE, 2025, 16
  • [45] Determinants of CRISPR Cas12a nuclease activation by DNA and RNA targets
    Nalefski, Eric A.
    Kooistra, Remy M.
    Parikh, Ishira
    Hedley, Samantha
    Rajaraman, Karunya
    Madan, Damian
    NUCLEIC ACIDS RESEARCH, 2024, 52 (08) : 4502 - 4522
  • [46] Nanozyme-assisted amplification-free CRISPR/Cas system realizes visual detection
    Zhang, Yuan
    Yu, Wanpeng
    Wang, Man
    Zhang, Lei
    Li, Peifeng
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2024, 11
  • [47] Plasmonically Enhanced CRISPR/Cas13a-Based Bioassay for Amplification-Free Detection of Cancer-Associated RNA
    Liu, Lin
    Wang, Zheyu
    Wang, Yixuan
    Luan, Jingyi
    Morrissey, Jeremiah J.
    Naik, Rajesh R.
    Singamaneni, Srikanth
    ADVANCED HEALTHCARE MATERIALS, 2021, 10 (20)
  • [48] Iterative crRNA design and a PAM-free strategy enabled an ultra-specific RPA-CRISPR/Cas12a detection platform
    Mao, Xujian
    Xu, Jian
    Jiang, Jingyi
    Li, Qiong
    Yao, Ping
    Jiang, Jinyi
    Gong, Li
    Dong, Yin
    Tu, Bowen
    Wang, Rong
    Tang, Hongbing
    Yao, Fang
    Wang, Fengming
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [49] Amplification-free CRISPR-Cas13a assay for detection of Taura syndrome virus
    Liu, Jianying
    Li, Ye
    Cao, Hubei
    Yao, Sisi
    Hu, Keshun
    Zhao, Qian
    He, Runzhen
    Zhu, Ningyu
    Yu, Xiaoping
    Fang, Shaohua
    Huang, Jun
    AQUACULTURE REPORTS, 2023, 30
  • [50] Advances in amplification-free detection of nucleic acid: CRISPR/Cas system as a powerful tool
    Qian, Siwenjie
    Chen, Yanju
    Xu, Xiaoli
    Peng, Cheng
    Wang, Xiaofu
    Wu, Hui
    Liu, Yang
    Zhong, Xiaoping
    Xu, Junfeng
    Wu, Jian
    ANALYTICAL BIOCHEMISTRY, 2022, 643